are compounded glp 1 as effective Did the FDA Ban Semaglutide and Tirzepatide? Novo Nordisk Drops Hims &

February 2025: Novo Nordisk announced that semaglutide 2.4 mg would be available in Mexican pharmacies by April 2025, with an average 17.5% weight loss observed in pivotal trials

A recent study compared semaglutide and tirzepatide for weight loss and found that tirzepatide resulted in 2.4% more weight loss at 3 months, 4.3% more at 6 months, and 6.9% more at 12 months

This extended action is why its a once-weekly medication

These three mechanismsreduced hunger, delayed gastric emptying, and improved insulin secretionwork together to support sustainable weight loss without requiring extreme dietary restriction

Around 80% of participants lost at least 5% of their total body weight

doi: 10.1056/NEJMoa1812389 10 NealBPerkovicVMahaffeyKWde ZeeuwDFulcherGEronduNet al